Search Results - "Moser, Arthur J"

EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer by Sanders, Michael K., MD, Moser, Arthur J., MD, Khalid, Asif, MD, Fasanella, Kenneth E., MD, Zeh, Herbert J., MD, Burton, Steven, MD, McGrath, Kevin, MD

“…Background Stereotactic body radiotherapy (SBRT) has been approved for the treatment of locally advanced pancreatic cancer. Placement of gold fiducials is…”
Get full text

Added value of 3D-vision during robotic pancreatoduodenectomy anastomoses in biotissue (LAEBOT 3D2D): a randomized controlled cross-over trial by Zwart, Maurice J. W., Jones, Leia R., Balduzzi, Alberto, Takagi, Kosei, Vanlander, Aude, van den Boezem, Peter B., Daams, Freek, Rosman, Camiel, Lips, Daan J., Moser, Arthur J., Hogg, Melissa E., Busch, Olivier R. C., Stommel, Martijn W. J., Besselink, Marc G.

“…Background We tested the added value of 3D-vision on procedure time and surgical performance during robotic pancreatoduodenectomy anastomoses in biotissue…”
Get full text

Stereotactic body radiotherapy in the treatment of pancreatic adenocarcinoma in elderly patients by Kim, Carolyn H, Ling, Diane C, Wegner, Rodney E, Flickinger, John C, Heron, Dwight E, Zeh, Herbert, Moser, Arthur J, Burton, Steven A

“…Treatment of pancreatic adenocarcinoma in the elderly is often complicated by comorbidities that preclude surgery, chemotherapy and/or conventional external…”
Get full text

Artificial intelligence to assess body composition on routine abdominal CT scans and predict mortality in pancreatic cancer– A recipe for your local application by Hsu, Tzu-Ming Harry, Schawkat, Khoschy, Berkowitz, Seth J., Wei, Jesse L., Makoyeva, Alina, Legare, Kaila, DeCicco, Corinne, Paez, S. Nicolas, Wu, Jim S.H., Szolovits, Peter, Kikinis, Ron, Moser, Arthur J., Goehler, Alexander

“…Body composition is associated with mortality; however its routine assessment is too time-consuming. To demonstrate the value of artificial intelligence (AI)…”
Get full text

Performance with robotic surgery versus 3D- and 2D­laparoscopy during pancreatic and biliary anastomoses in a biotissue model: pooled analysis of two randomized trials by Zwart, Maurice J. W., Jones, Leia R., Fuente, Ignacio, Balduzzi, Alberto, Takagi, Kosei, Novak, Stephanie, Stibbe, Luna A., de Rooij, Thijs, van Hilst, Jony, van Rijssen, L. Bengt, van Dieren, Susan, Vanlander, Aude, van den Boezem, Peter B., Daams, Freek, Mieog, J. Sven D., Bonsing, Bert A., Rosman, Camiel, Festen, Sebastiaan, Luyer, Misha D., Lips, Daan J., Moser, Arthur J., Busch, Olivier R., Abu Hilal, Mohammad, Hogg, Melissa E., Stommel, Martijn W. J., Besselink, Marc G.

“…Background Robotic surgery may improve surgical performance during minimally invasive pancreatoduodenectomy as compared to 3D- and 2D-laparoscopy but…”
Get full text

Braden scale for pressure ulcer risk predicts rehabilitation placement after pancreatic resection by Watkins, Ammara A., Castillo-Angeles, Manuel, Calvillo-Ortiz, Rodrigo, Guetter, Camila R., Eskander, Mariam F., Ghaffarpasand, Eiman, Anguiano-Landa, Luis, Tseng, Jennifer F., Moser, Arthur J., Callery, Mark P., Kent, Tara S.

“…Patients undergoing pancreatic resection frequently require rehabilitation facilities after hospital discharge. We evaluated the predictive role of validated…”
Get full text

The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology by Khalid, Asif, McGrath, Kevin M, Zahid, Maliha, Wilson, Matt, Brody, Debra, Swalsky, Patricia, Moser, Arthur J, Lee, Kenneth K, Slivka, Adam, Whitcomb, David C, Finkelstein, Sydney

“…Current methods to detect malignancy in mucinous cystic neoplasms of the pancreas remain inadequate. The role of detailed molecular analysis in this context…”
Get more information

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer by RAMANATHAN, Ramesh K, LEE, Kenneth M, DAY, Roger, TROETSCHEL, Monica, FINN, Olivera J, MCKOLANIS, John, HILTBOLD, Elizabeth, SCHRAUT, Wolfgang, MOSER, Arthur J, WARNICK, Elizabeth, WHITESIDE, Theresa, OSBORNE, Jennifer, HYOUNG KIM

“…MUC1 is a glycoprotein overexpressed in tumors as a hypoglycosylated form. A vaccine composed of a 100-amino acid peptide corresponding to five 20-amino acid…”
Get full text

EUS-Guided Fiducial Placement for Stereotactic Radiosurgery in Pancreatic Cancer by Sanders, Michael K, Khalid, Asif, Fasanella, Kenneth E, Zeh, Herbert, Moser, Arthur J, Burton, Steven A, Mcgrath, Kevin

Get full text

953 Loss of Heterozygosity Portends Poor Survival of Patients with Resected Periampullary Cancer by Franko, Jan, Krasinskas, Alyssa M, Nikiforova, Marina N, Nikiforov, Yuri E, Hughes, Steven J, Lee, Kenneth K, Bartlett, David L, Zeh, Herbert, Moser, Arthur J

Get full text

Primary duodenal carcinoma showing divergent growth patterns as determined by microdissection-based mutational genotyping by Cheung, Onki, Kandil, Hossam, Moser, Arthur J, Swalsky, Patricia A, Sasatomi, Eizaburo, Finkelstein, Sydney D

“…Primary duodenal adenocarcinoma accounts for less than 0.5% of all gastrointestinal cancers. We report a case of duodenal adenocarcinoma with highly divergent…”
Get full text

Neoadjuvant therapy versus upfront surgery for pancreatic adenocarcinoma: A propensity score matched analysis of short-term outcomes by Kasumova, Gyulnara G., de Geus, Susanna W.L., Tabatabaie, Omidreza, Fadayomi, Ayotunde B., Miksad, Rebecca A., Ng, Sing Chau, Moser, Arthur J., Hidalgo, Manuel M., Tseng, Jennifer F.

“…Abstract only 361 Background: Neoadjuvant therapy is increasingly utilized and has demonstrated a survival advantage in borderline and locally advanced…”
Get full text

Palliative reoperation for recurrent periampullary adenocarcinoma: Primum non nocere? by Boone, Brian A., Moser, Arthur J., Mock, Brady K., Johnson, Paul J., Dvorchik, Igor, Zeh, Herbert J., Marsh, J. Wallis

“…Abstract only 257 Background: A majority of patients with periampullary cancer develop local or metastatic recurrence despite successful R0 resection. Many of…”
Get full text

High-volume centers for pancreatic cancer surgery: Does the media message matter? by Chau, Zeling, Smith, Jillian K, West, James K., Zhou, Zheng, McDade, Theodore P., Ng, Sing Chau, Whalen, Giles Francis, Moser, Arthur J., Tseng, Jennifer F.

“…Abstract only 297 Background: Hospital procedure volume is associated with pancreatic cancer outcomes. However, differences between high-volume hospitals are…”
Get full text

Utilization of laparoscopy for resections of stomach and esophagus cancers: Is hospital the deciding factor? by Bliss, Lindsay A., Chau, Zeling, Yang, Catherine J., Smith, Jillian K., Witkowski, Elan R., Ragulin-Coyne, Elizaveta, Ng, Sing Chau, Critchlow, Jonathan F., Moser, Arthur J., Tseng, Jennifer F.

“…Abstract only 86 Background: Foregut surgery is technically complex. Outcomes for such high-stakes operations receive increasing scrutiny and the use of…”
Get full text

Detection of resectable pancreatic cancer with SOMAmer proteomic technology by Brand, Randall, Buchholz, Malte, Mehan, Mike, Whitcomb, David C., Zeh, Herbert, Moser, Arthur J, Gress, Thomas M, Williams, Steve, dela Cruz, Maria, Ostroff, Rachel

“…Abstract only 162 Background: To improve the current dismal 5-year survival rates for pancreatic adenocarcinoma (PC) it is essential to develop strategies…”
Get full text

Pancreaticoduodenectomy versus radiosurgery for octogenarians with pancreatic head adenocarcinoma by Hogg, Melissa Ellen, Kim, Carolyn H, Boone, Brian A., Lee, Kenneth K, Moser, Arthur J., Bartlett, David L, Heron, Dwight Earl, Burton, Steven A., Zeh, Herbert J., Zureikat, Amer H.

“…Abstract only 220 Background: Recent reports have justified pancreaticoduodenectomy (PD) in octogenarians. Given the morbidity of PD and the increasing…”
Get full text

Phase II trial of fixed-dose rate gemcitabine, bevacizumab, and concurrent 30 gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma by Van Buren, George, Ramanathan, Ramesh K., Krasinskas, Alyssa M, Smith, Ryan, Abood, Gerard J., Shuai, Yongli, Potter, Douglas M., Bahary, Nathan, Lembersky, Barry C., Zureikat, Amer H, Bartlett, David L., Zeh, Herbert, Moser, Arthur J

“…Abstract only 258 Background: Effective multimodality treatment for localized pancreatic cancer is elusive. We hypothesized that preoperative fixed-dose rate…”
Get full text

Margin distance as an independent predictor of survival after R0 resection for pancreatic adenocarcinoma by Van Buren, George, Zeh, Herbert, Krasinskas, Alyssa M, Gooding, William E., Steve, Jennifer, Lee, Kenneth K, Magge, Deepa, Daouadi, Mustapha, Bartlett, David L., Moser, Arthur J, Zureikat, Amer H

“…Abstract only 321 Background: Microscopic tumor at the surgical margin is a predictor of recurrence and poor survival for pancreatic ductal adenocarcinoma…”
Get full text

Hemosuccus pancreaticus presenting as massive, recurrent upper gastrointestinal bleeding. Control by angiographic embolization by Khalid, Asif, Moser, Arthur J, Slivka, Adam

Get full text